Enter Your Practice Information





Yes No

Yes No


X
x

Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  • Registration for new subscribers will open in August 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Journal May 2012 (Vol 34, No 5)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Hypercoagulability in Dogs: Treatment by Dianne Kittrell , DVM, DACVIM, Larry Berkwitt , DVM, DACVIM

1. Which statement regarding venous thrombi is false?
2. Which statement regarding arterial thrombi is true?
3. Which of the following statements regarding antiplatelet drugs is true?
4. Heparin enhances the activity of which anticoagulant?
5. Which statement regarding unfractionated heparin or LMWH is true?
6. Which of the following is a recognized limitation of unfractionated heparin use?
7. Which is not a characteristic of LMWH?
8. Which statement regarding warfarin therapy is false?
9. _______ requires close monitoring to prevent hemorrhagic complications associated with its use.
10. Which statement regarding fibrinolytic therapy is false?
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More
Subscribe